Humate-P

Revision as of 00:28, 8 September 2016 by Mholtz (talk | contribs)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Background

  • Human Plasma-derived von Willebrand Factor
  • Contains both vWF and factor VIII

Indications

  • Hemophilia A (can also use factor VIII, FFP does not work well)
  • Von Willebrand disease that is unresponsive to DDAVP (can also use cryoprecipitate, FFP does not work well)

Contraindications

  • Allergy to class/drug

Administration

  • Type:
  • Dosage Forms:
  • Routes of Administration:
  • Common Trade Names:

Adult Dosing

Pediatric Dosing

Special Populations

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References